infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 38 articles.

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • WHO issues its first hepatitis B treatment guidelines

    World Health Organization / 12 March 2015

  • Hepatitis Quest Moves From C to B Under Former Gilead Executives

    Bloomberg / 05 February 2015

  • FDA places Arrowhead Hepatitis B drug on partial hold, shares plunge

    Reuters / 13 January 2015

  • Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company

    Tekmira press release / 13 January 2015

  • After hepatitis C cure, companies target next big liver disease market

    Yahoo News / 10 November 2014

  • Doctors Battle Insurers for Access to Pricey Hepatitis C Drugs

    Healthline / 09 September 2014

  • Costs for Hepatitis C Treatment Skyrocket

    Medscape (requires registration) / 14 November 2013

  • Liver transplant outcomes among HBV patients improved over time

    Healio Hepatology / 07 October 2013

  • Medivir and Daewoong pull plug on hepatitis B drug

    PharmaTimes / 06 September 2013

  • Besifovir noninferior to entecavir for chronic HBV in phase 2b trial

    Healio Hepatology / 29 August 2013

← Prev1234Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//